title: [The preliminary results of using tramal in rheumatoid arthritis patients].
abstract: Patients suffering from active rheumatoid arthritis (RA) were examined for the analgesic effect of tramal. All the patients were administered basic therapy and nonsteroidal anti-inflammatory drugs. Tramal produced a beneficial effect in 79% of the patients. The stable analgesic effect ensued on days 3-5 since the onset of continuous treatment. Provided the drug was administered for a short period of time (not more than 14 days), addiction to tramal was not recorded. Only 11% of the patients demonstrated tramal-induced side effects (drowsiness, dizziness, skin itch), seen in cases where the daily dose exceeded 300 mg.
authors.forename: V I
authors.initials: VI
authors.lastname: Makolkin
authors.forename: N N
authors.initials: NN
authors.lastname: Bazhanov
authors.forename: N V
authors.initials: NV
authors.lastname: Petukhova
authors.forename: I V
authors.initials: IV
authors.lastname: Men'shikova
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors; D014147:Tramadol / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014147:Tramadol
vernacular_title: Predvaritel'nye rezul'taty ispol'zovaniia tramala u bol'nykh revmatoidnym artritom.